Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study

QR Code

Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study

Bernardo Dell&rsquo;Osso, Chiara Arici, Cristina Dobrea, Giulia Camuri, Beatrice Benatti, A Carlo AltamuraUniversity of Milan, Department of Psychiatry, Fondazione IRCSS Ca&rsquo; Granda, Ospedale Maggiore Policlinico, Milano, ItalyBackground: Escitalopram is a selective serotonin re...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Dell&#39;Osso B, Arici C, Dobrea C, Camuri G, Benatti B, Altamura AC
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2013
Sujets:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/a8b909c40d56453eadc60169f33f3b5a
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Ten-year outcome of vagus nerve stimulation-implanted patients with treatment-resistant depression: two Italian cases
par: Dell'Osso B, et autres
Publié: (2018)

Methylphenidate augmentation of escitalopram to enhance adherence to antidepressant treatment: a pilot randomized controlled trial
par: Martin P. Paulus, et autres
Publié: (2021)

Safety of escitalopram in pregnancy: a case series
par: Bellantuono C, et autres
Publié: (2013)

Duloxetine in panic disorder with somatic gastric pain
par: Preve M, et autres
Publié: (2013)

Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
par: Kishi T, et autres
Publié: (2017)

The therapeutic potential of escitalopram in the treatment of panic disorder
par: Mark H Townsend, et autres
Publié: (2007)

Comparative efficacy of escitalopram in the treatment of major depressive disorder
par: Mazen K Ali, et autres
Publié: (2011)

Efficacy and safety of generic escitalopram (Lexacure®) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram-comparative, non-inferiority study
par: Jeong JH, et autres
Publié: (2015)

Efficacy and tolerability of escitalopram in treatment of major depressive disorder with anxiety symptoms: a 24-week, open-label, prospective study in Chinese population
par: Jiang KD, et autres
Publié: (2017)

Comparative safety and efficacy of tibolone and escitalopram in postmenopausal women
par: Rajnish Raj, et autres
Publié: (2021)

Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review
par: Maneeton B, et autres
Publié: (2018)

Long-term administration of escitalopram in patients with social anxiety disorder in Japan
par: Asakura S, et autres
Publié: (2016)

Safety and effectiveness of escitalopram in an 8-week open study in Chinese patients with depression and anxiety
par: Wang G, et autres
Publié: (2018)

Radiofrequency-targeted vertebral augmentation versus traditional balloon kyphoplasty: radiographic and morphologic outcomes of an ex vivo biomechanical pilot study
par: Dalton BE, et autres
Publié: (2012)

Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia
par: Ascher-Svanum H, et autres
Publié: (2012)

Dosage-related nature of escitalopram treatment-emergent mania/hypomania: a case series
par: Yamaguchi Y, et autres
Publié: (2018)

Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder
par: Berman R, et autres
Publié: (2011)

Covid effects on clinical outcomes of TMS treatment: a naturalistic study
par: A.IREM SONMEZ, et autres
Publié: (2021)

Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline
par: Huang J, et autres
Publié: (2018)

A prospective naturalistic study of antidepressant-induced jitteriness/anxiety syndrome
par: Harada T, et autres
Publié: (2014)

The utility of novel outcome measures in a naturalistic evaluation of schizophrenia treatment
par: Tompsett T, et autres
Publié: (2018)

Serotonin syndrome induced by the readministration of escitalopram after a short-term interruption in an elderly woman with depression: a case report
par: Sato Y, et autres
Publié: (2015)

S. AUREUS/C. ALBICANS MONO- AND DUAL-SPECIES BIOFILMS
par: O. N. Postnikova, et autres
Publié: (2018)

Evaluating depressive symptoms in mania: a naturalistic study of patients with bipolar disorder
par: Young AH, et autres
Publié: (2015)

Lower serum brain-derived neurotrophic factor levels are associated with failure to achieve remission in patients with major depression after escitalopram treatment
par: Lee BH, et autres
Publié: (2014)

Risk factors for the development of depression in patients with hepatitis C taking interferon-&alpha;
par: Smith KJ, et autres
Publié: (2011)

Comparative efficacy, acceptability, and tolerability of dexmethylphenidate versus placebo in child and adolescent ADHD: a meta-analysis of randomized controlled trials
par: Maneeton N, et autres
Publié: (2015)

Lithium treatment in bipolar adolescents: a follow-up naturalistic study
par: Masi G, et autres
Publié: (2018)

Clinical characteristics and long-term response to mood stabilizers in patients with bipolar disorder and different age at onset
par: Bernardo Dell&rsquo;Osso, et autres
Publié: (2009)

Efficacy and tolerability of topiramate-augmentation therapy for schizophrenia: a systematic review and meta-analysis of randomized controlled trials
par: Okuyama Y, et autres
Publié: (2016)

The social functional outcome of being naturalistically treated with paliperidone extended-release in patients with schizophrenia
par: Nakagawa R, et autres
Publié: (2015)

Thyroid functions in patients with bipolar disorder and the impact of quetiapine monotherapy: a retrospective, naturalistic study
par: Li C, et autres
Publié: (2019)

Effects of escitalopram with a Chinese traditional compound Jiuweizhenxin-keli on mismatch negativity and P50 in patients with major depressive disorders
par: Kuang W, et autres
Publié: (2016)

Southeastern naturalist
Publié: (2002)

Naturalistes Belges

Malaysian Naturalist

The Southwestern naturalist

Northeastern naturalist
Publié: (1997)

The American naturalist
Publié: (1868)

Naturalistic smartphone keyboard typing reflects processing speed and executive function
par: Mindy K. Ross, et autres
Publié: (2021)